Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
FENWICK v. RANBAXY PHARMACEUTICALS, INC. et al
Case Number:
3:12-cv-07354
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
-
November 14, 2018
Ranbaxy Consumers Denied Cert. In Drug Contamination Suit
A New Jersey federal judge Wednesday denied class certification in a suit claiming Ranbaxy Pharmaceuticals Inc. distributed pills that might have contained glass, saying there was not enough data to identify who got pills from the potentially affected batches.
-
March 26, 2018
Consumers Push For Cert. In Contaminated Ranbaxy Pills Suit
Consumers accusing Ranbaxy Pharmaceuticals Inc. of distributing cholesterol pills that might have contained glass particles urged a New Jersey federal judge Friday to certify a class of people who received the affected pills.
-
March 30, 2015
Ranbaxy Can't Nix Glass-Tainted Pill Class Action
A New Jersey federal judge on Friday denied Ranbaxy Laboratories Ltd.'s motion to dismiss a proposed class action brought by consumers claiming they're entitled to refunds because some batches of the company's generic version of the cholesterol drug Lipitor contained pieces of glass.
-
March 06, 2013
Ranbaxy Ducks Wider Recall In Glass Particles Class Action
A New Jersey federal judge Tuesday rejected a proposed class action's demand for a wider recall of Ranbaxy Laboratories Ltd.'s generic version of Lipitor, a setback for patients who claim pills tainted with glass pose a serious health risk.
-
March 05, 2013
Express Scripts Says Class Action's Recall Bid Hits FDA Turf
Pharmacy benefit manager Express Scripts Inc. on Monday asked a New Jersey federal judge to dispense with a proposed consumer class action seeking a wider recall of glass-tainted pills made by Ranbaxy Laboratories Ltd., saying the court has no authority to intrude on regulators' turf.
-
February 20, 2013
Ranbaxy Attacks Recall Demand In Glass Particles Action
Ranbaxy Laboratories Ltd. in New Jersey federal court Tuesday attacked a proposed class action targeting its generic version of Lipitor, questioning the honesty of patients allegedly harmed by pills potentially tainted with glass and saying a court-ordered larger recall would usurp regulators' authority.
-
January 28, 2013
Consumers Urge Wider Recall In Ranbaxy Glass Shards Action
Consumers who purchased Ranbaxy Laboratories Ltd.'s generic version of cholesterol drug Lipitor asked a New Jersey federal judge Friday to order a complete recall of pills tainted with glass shards, alleging in their proposed class action that reports of significant patient harm are emerging.
-
December 04, 2012
Ranbaxy Hit With Class Action Over Generic Lipitor Recall
Ranbaxy Inc. was hit with a putative class action filed in New Jersey federal court last week, alleging the company's recall of its generic version of blockbuster cholesterol treatment Lipitor did not warn or compensate consumers adequately of the drug.